Read + Share
Abbadessa G, Miele G, Cavalla P, Valentino P, et al. Previous disease-modifying treatments influence T lymphocyte kinetics in people
with multiple sclerosis switching to ocrelizumab. J Neuroimmunol 2023;378:578072.
PMID: 36996621
|
 |
|
Abbadessa G, Miele G, Cavalla P, Valentino P, et al. Previous disease-modifying treatments influence T lymphocyte kinetics in people
with multiple sclerosis switching to ocrelizumab. J Neuroimmunol 2023;378:578072.
PMID: 36996621
|
|
|
|